Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
about
Parkinson's Disease: From Pathogenesis to PharmacogenomicsCyclic ADP-ribose as an endogenous inhibitor of the mTOR pathway downstream of dopamine receptors in the mouse striatum.Iron-induced generation of mitochondrial ROS depends on AMPK activity.Local sympathetic denervation attenuates myocardial inflammation and improves cardiac function after myocardial infarction in mice.Gene Therapy for Parkinson's Disease, An Update.n-Propanol extract of boiled and fermented koro benguk ( seed) shows a neuroprotective effect in paraquat dichloride-induced Parkinson's disease rat model
P2860
Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tyrosine hydroxylase (TH), its ...... overview and future prospects.
@en
type
label
Tyrosine hydroxylase (TH), its ...... overview and future prospects.
@en
prefLabel
Tyrosine hydroxylase (TH), its ...... overview and future prospects.
@en
P2860
P1476
Tyrosine hydroxylase (TH), its ...... overview and future prospects.
@en
P2093
Ikuko Nagatsu
Toshiharu Nagatsu
P2860
P2888
P356
10.1007/S00702-016-1596-4
P577
2016-08-04T00:00:00Z